5avi
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='5avi' size='340' side='right'caption='[[5avi]], [[Resolution|resolution]] 2.70Å' scene=''> | <StructureSection load='5avi' size='340' side='right'caption='[[5avi]], [[Resolution|resolution]] 2.70Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5avi]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[5avi]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5AVI OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5AVI FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4KM:TERT-BUTYL+2-[[4-[ETHANOYL(METHYL)AMINO]PHENOXY]METHYL]-5-(TRIFLUOROMETHYL)BENZOATE'>4KM</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=4KM:TERT-BUTYL+2-[[4-[ETHANOYL(METHYL)AMINO]PHENOXY]METHYL]-5-(TRIFLUOROMETHYL)BENZOATE'>4KM</scene></td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5avi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5avi OCA], [https://pdbe.org/5avi PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5avi RCSB], [https://www.ebi.ac.uk/pdbsum/5avi PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5avi ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Disease == | == Disease == | ||
- | [ | + | [https://www.uniprot.org/uniprot/NCOA1_HUMAN NCOA1_HUMAN] Note=A chromosomal aberration involving NCOA1 is a cause of rhabdomyosarcoma. Translocation t(2;2)(q35;p23) with PAX3 generates the NCOA1-PAX3 oncogene consisting of the N-terminus part of PAX3 and the C-terminus part of NCOA1. The fusion protein acts as a transcriptional activator. Rhabdomyosarcoma is the most common soft tissue carcinoma in childhood, representing 5-8% of all malignancies in children. |
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/NCOA1_HUMAN NCOA1_HUMAN] Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Involved in the coactivation of different nuclear receptors, such as for steroids (PGR, GR and ER), retinoids (RXRs), thyroid hormone (TRs) and prostanoids (PPARs). Also involved in coactivation mediated by STAT3, STAT5A, STAT5B and STAT6 transcription factors. Displays histone acetyltransferase activity toward H3 and H4; the relevance of such activity remains however unclear. Plays a central role in creating multisubunit coactivator complexes that act via remodeling of chromatin, and possibly acts by participating in both chromatin remodeling and recruitment of general transcription factors. Required with NCOA2 to control energy balance between white and brown adipose tissues. Required for mediating steroid hormone response. Isoform 2 has a higher thyroid hormone-dependent transactivation activity than isoform 1 and isoform 3.<ref>PMID:9427757</ref> <ref>PMID:7481822</ref> <ref>PMID:9223431</ref> <ref>PMID:9296499</ref> <ref>PMID:9223281</ref> <ref>PMID:10449719</ref> <ref>PMID:12954634</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 29: | Line 27: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | + | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Hanzawa | + | [[Category: Hanzawa H]] |
- | [[Category: Matsui | + | [[Category: Matsui Y]] |
- | [[Category: Tamaki | + | [[Category: Tamaki K]] |
- | + | ||
- | + | ||
- | + |
Revision as of 06:27, 31 May 2023
Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4
|